Skip to content

A Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor

A Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27554
Enrollment
82
Registered
2014-03-06
Start date
2014-05-30
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

None listed

Sponsors

Senseonics Inc. 20451 Seneca Meadows Parkway Germantown, Maryland, 20876
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Males and Females ≥18 years of age. 2. Clinically confirmed diagnosis of diabetes mellitus for a duration of 1 year and uses insulin therapy for their diabetes management (including subjects on insulin pump therapy).

Exclusion criteria

Exclusion criteria: 1. History of severe hypoglycemia in the last 6 months prior to study start 2. Diabetic ketoacidosis in the past 6 months. 3. Any condition preventing or complicating the placement, operation or removal of the Sensor including upper extremity deformities or skin condition. 4. Any medical condition or illness that in the judgment of the investigator might interfere with the procedures, results or compliance during the course of this investigation, or increase the risk of induced hypoglycemia or repeated blood testing including significantly impaired hepatic function and renal failure.

Design outcomes

Primary

MeasureTime frame
The primary effectiveness endpoint will be evaluated in a test of superiority to a pre-specified performance goal for accuracy. Mean absolute relative difference (MARD) of Sensor readings will be compared with the reference measurements (YSI) at successive 30-days intervals through 180 days post-insertion. for reference glucose values greater than 75 mg/dL (4.2 mmol/L

Secondary

MeasureTime frame
1. Mean absolute difference for reference glucose values less than 75 mg/dL (4.2 mmol/L). 1.2. Additional accuracy measures during the period of Sensor use – mean absolute difference; median absolute relative difference; agreement as expressed by readings within 20%, 30% and 40% of reference values; trend accuracy measured over time at different glucose rates of change and starting ranges

Contacts

Public ContactCaroll Cummings

Senseonics Inc. 20451 Seneca Meadows Parkway Germantown, Maryland, 20876

carroll.cummings@senseonics.com301.515.7260

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)